BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2179961)

  • 21. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine.
    Hsieh LL; Hsiao WL; Peraino C; Maronpot RR; Weinstein IB
    Cancer Res; 1987 Jul; 47(13):3421-4. PubMed ID: 3555772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of retroviral sequences and oncogenes in murine hepatocellular tumors.
    Dragani TA; Manenti G; Della Porta G; Gattoni-Celli S; Weinstein IB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1915-9. PubMed ID: 3004709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
    Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
    Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
    Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
    Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
    Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
    Mol Carcinog; 2002 Oct; 35(2):93-102. PubMed ID: 12325039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proto-oncogene and gap-junction protein expression in rodent liver neoplasms.
    Beer DG; Neveu MJ
    Prog Clin Biol Res; 1990; 331():293-309. PubMed ID: 1969160
    [No Abstract]   [Full Text] [Related]  

  • 34. Oncogenes in mouse liver tumors.
    Anderson M; Stanley L; Devereux T; Reynolds S; Maronpot R
    Prog Clin Biol Res; 1992; 376():187-201. PubMed ID: 1528919
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of the methylation status of the 5' flanking region of Ha-ras in B6C3F1, C3H/He and C57BL/6 mouse liver.
    Counts JL; Goodman JI
    Cancer Lett; 1993 Dec; 75(2):129-36. PubMed ID: 8293423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and epigenetic promotion of murine hepatocarcinogenesis.
    Drinkwater NR; Hanigan MH; Kemp CJ
    Prog Clin Biol Res; 1990; 331():163-76. PubMed ID: 2156269
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic progression in mouse models for liver tumors.
    Tward AD; Jones KD; Yant S; Kay MA; Wang R; Bishop JM
    Cold Spring Harb Symp Quant Biol; 2005; 70():217-24. PubMed ID: 16869757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of oncogene and its expression at cellular level].
    Hirohashi S
    Hum Cell; 1988 Mar; 1(1):17-9. PubMed ID: 3154011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.
    Thompson TC; Southgate J; Kitchener G; Land H
    Cell; 1989 Mar; 56(6):917-30. PubMed ID: 2538247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-myc gene effects on cell growth and transformation.
    Sorrentino V; Drozdoff V; Zeitz L; Fleissner E
    Ann N Y Acad Sci; 1987; 511():329-37. PubMed ID: 3326468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.